NYSE : SPE

Special Opportunities Fund, Inc.

$13.59 USD

-$0.05 (-0.37%)

Volume
28.38K
Average Volume
34.81K
Market Capitalization
$144.37M
P/E Ratio
7.81
Dividend Yield
19.83%
Price Target
Year High
$15.99
Year Low
$13.14
Day High
Day Low
Payout Ratio
$0.74
Current Ratio
$0.00
Company Overview

NYSE

Phillip Franklin Goldstein

Asset Management

Financial Services

SPE

N/A

US

USD

201-556-0092

84741T104

0000897802

Liquidity Metrics

0.00

0.00

0.00

0.00

0.74

Sales & Valuation

$22.06M

6.54

0.67

9.25

1.39

Profitability

$1.84

$21.08M

95.53%

95.53%

9.05%

8.90%

P/E Metrics

7.81

-0.17

-0.17

Analyst Price Target & Rating

Buy

4/5

0 Analysts

%

Poll Results

About Special Opportunities Fund, Inc. (NYSE:SPE) Stock

Special Opportunities Fund, Inc., overseen by Bulldog Investors, LLC, operates as a closed-end balanced "fund of funds." This investment vehicle primarily deploys capital into other closed-end funds that hold positions in public equity and fixed-income securities. Its investment methodology is characterized by a blend of value-driven, opportunistic, and special situations strategies. The fund's performance is benchmarked against the S&P 500 Index. Historically, it was known as the Insured Municipal Income Fund, Inc. Formed on February 18, 1993, the fund is domiciled in the United States. ...

Special Opportunities Fund Announces Distributions For Third Quarter of 2026

2026-07-01 10:41:00

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Special Opportunities Fund, Inc. (NYSE: SPE) (the “Fund”) today announced that the Fund's Board of Directors (the “Board”) has declared the next three monthly distributions under the Fund's managed distribution plan.

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myel

2026-06-13 07:00:00

New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combi

Frequently Asked Questions

What is the current Special Opportunities Fund, Inc. (SPE) stock price?

Special Opportunities Fund, Inc.(NYSE:SPE) stock price is $13.59 in the last trading session. During the trading session, SPE stock reached the peak price of $15.99 while $13.14 was the lowest point it dropped to. The percentage change in SPE stock occurred in the recent session was --0.37% while the dollar amount for the price change in SPE stock was -$0.05.

SPE's industry and sector of operation?

The NYSE listed SPE is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of SPE?

Stephanie Lynne Darling | Chief Compliance Officer
Thomas Antonucci | Chief Financial Officer & Treasurer
Andrew Dakos | President & Interested Director
Phillip Franklin Goldstein | Chairman & Secretary
|

How many employees does SPE have?

Number of SPE employees currently stands at None. SPE operates from Park 80 West - Plaza Two, Saddle Brook, NJ 07663, US.

Link for SPE official website?

How do I contact SPE?

SPE could be contacted at phone #201-556-0092 and can also be accessed through its website. SPE operates from Park 80 West - Plaza Two, Saddle Brook, NJ 07663, US.

How many shares of SPE are traded daily?

The average number of SPE shares traded daily for last 3 months was 34.81K.

What is the market cap of SPE currently?

The market value of SPE currently stands at $144.37M with its latest stock price at $13.59